Aptar nasal system delivers FDA-approved heart rhythm drug CARDAMYST

Go back to Aptar nasal system delivers FDA-approved heart rhythm drug CARDAMYST
APTARGROUP, Inc. (NYSE: ATR) Delayed: 123.88 +0.01 (0.01%)
Previous Close $123.87    52 Week High $81.50 
Open $122.89    52 Week Low $66.33 
Day High $124.11    P/E 49.16 
Day Low $122.09    EPS $2.52 
Volume 27,760       

(NASDAQ: MIST) Delayed: 0.80 +0.01 (1.27%)
Previous Close $0.79    52 Week High $ 
Open $0.78    52 Week Low $ 
Day High $0.82    P/E N/A 
Day Low $0.78    EPS $ 
Volume 138,018